In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche/Genentech: A Case Study For Future Hostile Offers

Executive Summary

It's almost a certainty that five years from now gurus at top-notch B-schools will include the Roche/Genentech saga as a critical case-study in how-or how not-to acquire a partner. They will laud--or criticize--Severin Schwan, Roche's new CEO, for his chutzpah, pending the outcome of the ensuing weeks.
Advertisement

Related Content

Business Development at Roche and Genentech: An Interview with Joe McCracken and Dan Zabrowski
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q1 2009
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q1 2009
Bristol-Myers Squibb and Otsuka Stabilize Their Bases
Bristol-Myers Squibb and Otsuka Stabilize Their Bases
In Bid For Genentech, How High Can Roche Go?
After Roche/Genentech: Pharma's Focus on Efficiencies, Not Innovation
After Roche/Genentech: Pharma's Focus on Efficiencies, Not Innovation

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003261

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel